CT-P13 Effectiveness in Management of Crohn’s Disease and Ulcerative Colitis
The following is a summary of “Efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis,” published in the November 2024 issue of Gastroenterology ...